The dollar slipped on Friday after a media report on early signs that a COVID-19 treatment drug was working, as well as optimism about re-opening the world's largest economy, encouraged investors in to riskier currencies.

The Australian and New Zealand dollars led gains, with the kiwi jumping as much as 1% to $0.6023, while the pound and euro also rose to recoup some of the past two days' losses.

Medical news website STAT, citing a recorded discussion between doctors involved in a clinical trial, said most of 125 patients given Gilead's remdesivir drug at a hospital in Chicago had recovered and been discharged.

The dollar last sat at $1.0857 per euro and $1.2486 per pound and a fraction weaker at 107.83 yen . The Australian and New Zealand dollars held just below session highs, with the Aussie at $0.6363 and the kiwi at $0.5998.

Source : Reuters